-
Sat23Mar2019Thu28Mar2019
-
Wed27Mar2019Fri29Mar2019
-
Thu11Apr2019Fri12Apr2019
-
Fri12Apr2019
-
Mon15Apr2019Thu18Apr2019
-
Fri26Apr2019Sat27Apr2019
-
Thu09May2019Sat11May2019
-
Mon13May2019Sat18May2019
Latest News
UK MHRA forms Expert Advisory Group to review paclitaxel devices while...
The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK and the Food and Drug Administration (FDA) in the USA have both recently...
Features
Paclitaxel-releasing devices: An unfolding story
Paclitaxel Timeline:
Meta-analysis finds a higher risk of death in the long term when paclitaxel-coated devices are used in the leg
Without additional long-term...
Depression and peripheral arterial disease: A call to action
With “an indisputable association between depression and peripheral arterial disease (PAD)”—nearly a third of PAD patients experience comorbid depression or depressive symptoms—Joel Ramirez and...
Videos
Jan Blankensteijn (Amsterdam, The Netherlands; principal investigator of the DREAM trial) tells Vascular News about what inspired him to design the DREAM trial, how its findings became particularly important with the long-term follow-up data for endovascular aneurysm repair (EVAR)...
(Visited 63,007 times, 55 visits today)
